AN-215

N/A

Report date: 2023/12/05 15:27:26

Base Information

Drug NameAN-215
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionTopoisomerase (DNA) II alpha inhibitorsGastrin-releasing peptide antagonists
TargetsTopoisomerase (DNA) II alphaGastrin-releasing peptide
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTulane University School Of MedicineCOSCIENS Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTulane University School Of MedicineCOSCIENS Biopharma Inc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A